Skip to main content
OpenTrials
Completed

NCT Number: NCT07181044

Exercise, IMA and Sulfhydryl Biomarkers in Young Women

Background: Regular physical activity exerts systemic health benefits that extend to redox homeostasis and antioxidant defense mechanisms. Ischemia-modified albumin (IMA) and total sulfhydryl groups (-SH) are increasingly recognized as sensitive biomarkers reflecting oxidative protein modification and thiol-dependent antioxidant capacity, respectively. However, data on their interplay in young women engaged in structured exercise remain scarce.

Objective: This study aimed to investigate the effects of regular exercise on serum IMA and -SH concentrations in healthy young women, thereby providing insights into exercise-induced redox remodeling and sex-specific physiological adaptations.

Methods: A cross-sectional design was employed involving 30 healthy women aged 18-25 years. Participants were divided into an exercise group (n = 15), who had performed structured training ≥3 sessions per week for at least one year, and a control group (n = 15) with no structured exercise history. Venous blood samples were collected after overnight fasting. Serum IMA was quantified using the albumin-cobalt binding assay, and -SH concentrations were determined via the Ellman method. All analyses were performed in duplicate under standardized laboratory conditions. Independent samples t-tests were applied, and effect sizes (Cohen's d) were calculated with 95% confidence intervals.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–25 year

Sex eligibility

Female

Study type

Observational

Primary location

Yüzüncü Yıl University, Central Research Laboratory

Van, Muş, 49100, Turkey (Türkiye)

About this study

Regular physical activity is widely recognized as a key determinant of human health, conferring benefits across cardiovascular, metabolic, endocrine, and immune systems. Beyond traditional outcomes, habitual exercise plays a pivotal role in regulating oxidative stress and maintaining redox homeostasis. However, few studies have concurrently investigated ischemia-modified albumin (IMA), a marker of oxidative protein modification, and total sulfhydryl groups (-SH), a marker of thiol-dependent antioxidant defense, particularly in young women. The present study was therefore designed to provide novel insights into exercise-induced redox adaptations in this underrepresented population.

This investigation employed an observational, cross-sectional design conducted in accordance with the STROBE guidelines for reporting observational research. Ethical approval was granted by the Muş Alparslan University Scientific Research Ethics Committee (Approval No: 27750; 01 November 2021), and all procedures complied with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to data collection.

A total of 30 healthy women aged 18-25 years were recruited. Participants were categorized into two groups:

Exercise group (n = 15): Women who had been consistently engaged in structured training for at least 12 months, with a minimum frequency of three sessions per week. Training programs were multimodal and typically included aerobic exercise (e.g., running, cycling, swimming at 60-75% HRmax for 20-30 minutes), resistance training (3 sets of 8-12 repetitions at moderate-to-high intensity, targeting major muscle groups), and flexibility exercises incorporated during warm-up and cool-down phases. Training sessions were supervised by qualified instructors in university or private facilities to ensure adherence to safety standards.

Control group (n = 15): Women without a history of structured exercise, whose activity levels were limited to daily living tasks and compulsory school-based physical education.

Exclusion criteria

included chronic cardiovascular, metabolic, or endocrine disorders; smoking or alcohol use; recent use of medications or supplements known to influence oxidative stress; and irregular or intermittent exercise participation. Baseline health screening confirmed all participants were free from chronic illness and suitable for inclusion.

Venous blood samples were collected from the antecubital vein between 07:00 and 09:00 a.m. following an overnight fast of at least 10 hours. Participants refrained from strenuous physical activity, alcohol, and caffeine for 24 hours prior to sampling. Serum was separated by centrifugation and stored at -80 °C until analysis.

Ischemia-modified albumin (IMA): Determined using the albumin-cobalt binding assay (Bar-Or method). Absorbance was measured at 470 nm, expressed in absorbance units (ABSU).

Total sulfhydryl groups (-SH): Measured using the Ellman method, based on the reduction of DTNB and expressed as μmol/L.

All analyses were conducted in duplicate, with strict internal quality control procedures, including calibration curves and reagent blanks. A single trained biochemist blinded to group allocation performed all assays to minimize analytical bias.

Statistical analyses were performed using IBM SPSS Statistics 22.0. Normality was assessed using the Shapiro-Wilk test, and group comparisons were made using independent samples t-tests. Effect sizes (Cohen's d) with 95% confidence intervals were calculated to assess the magnitude of differences.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy women aged 18-25 years
  • For exercise group: Regular structured training ≥3 sessions per week for at least 12 months
  • For control group: No structured exercise background, only daily living activity

Exclusion criteria

  • History of chronic cardiovascular, metabolic, or endocrine disorders
  • Smoking or alcohol abuse
  • Current or recent use (past 6 months) of medications or supplements influencing oxidative stress or hormonal regulation
  • Irregular or intermittent exercise participation not meeting the defined threshold

Treatment and study plan

Primary outcomes

  1. Serum Ischemia-Modified Albumin (IMA)

    Time frame: Baseline (single fasting blood draw)

    Change in serum ischemia-modified albumin (IMA) concentration, measured in absorbance units (ABSU) using the albumin-cobalt binding assay.

Secondary outcomes

  1. Serum Total Sulfhydryl Groups (-SH)

    Time frame: Baseline (single fasting blood draw)

    Change in serum total sulfhydryl (-SH) concentration, measured in μmol/L using the Ellman method.

Sponsors and collaborators

Lead sponsor

Duvenciler Anadolu Lİsesi

Other

Registry information

Official study title

Effects of Regular Exercise on Ischemia-Modified Albumin and Total Sulfhydryl Levels in Young Women

Acronym: IMA-SH & Exerc

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Sep 18, 2025
Registry last updated
Sep 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.